Carter D B, Deibel M R, Dunn C J, Tomich C S, Laborde A L, Slightom J L, Berger A E, Bienkowski M J, Sun F F, McEwan R N
Department of Molecular Biology Research, Upjohn Company, Kalamazoo, Michigan 49007.
Nature. 1990 Apr 12;344(6267):633-8. doi: 10.1038/344633a0.
A human myelomonocytic cell line, U937, produced an interleukin-1 (IL-1) receptor antagonist protein (IRAP) which was purified and partially sequenced. A complementary DNA coding for IRAP was cloned and sequenced. The mature translation product of the cDNA has been expressed in Escherichia coli and was an active competitive inhibitor of the binding of IL-1 to the T-cell/fibroblast form of the IL-1 receptor. Recombinant IRAP specifically inhibited IL-1 bioactivity on T cells and endothelial cells in vitro and was a potent inhibitor of IL-1 induced corticosterone production in vivo.
人骨髓单核细胞系U937产生一种白细胞介素-1(IL-1)受体拮抗剂蛋白(IRAP),该蛋白经纯化并进行了部分测序。编码IRAP的互补DNA被克隆并测序。该cDNA的成熟翻译产物已在大肠杆菌中表达,是IL-1与T细胞/成纤维细胞形式的IL-1受体结合的活性竞争性抑制剂。重组IRAP在体外特异性抑制IL-1对T细胞和内皮细胞的生物活性,并且在体内是IL-1诱导的皮质酮产生的有效抑制剂。